Catherine Bresson

Director, Operational Team, WIN Consortium

Vladimir Lazar

Chief Scientific and Operating Officer, WIN Consortium

Razelle Kurzrock

Associate Director, Clinical Science, Director, Center for Personalized Cancer Therapy, Director, Rare Tumor Clinic, University of California San Diego Moores Cancer Center (USA)

Brian Leyland-Jones

Chief Medical Officer, National Foundation for Cancer Research; Chief Scientific Officer, The Darwin Foundation (USA)

Amir Onn

Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Jacques Raynaud

Member of Board and Past President, Fondation ARC for cancer research (France), Advisor to Operational Team, WIN Consortium

Richard L. Schilsky

Principal Investigator, TAPUR Study, American Society of Clinical Oncology (ASCO); past ASCO Executive Vice President and Chief Medical Officer (2013-2021)

Josep Tabernero

Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain); Past ESMO President (2019)

Catherine Bresson

Director, Operational Team, WIN Consortium

Vladimir Lazar

Chief Scientific and Operating Officer, WIN Consortium

Layla El-Gharras

Assistant, Operational Team, WIN Consortium

Shai Magidi

IT Data Manager, WIN Consortium

Jacques Raynaud

Member of Board and Past President, Fondation ARC for cancer research (France), Advisor to Operational Team, WIN Consortium

Eitan Rubin

Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head Bioinformatics, WIN Consortium

Hila Ventura

Data Manager, WIN Consortium

Fanny Wunder

Project Manager, WIN Consortium

Andrea Califano

Chair of Department of Systems Biology, Columbia University (USA); Vice Chairman of WIN SAB

Phillip Febbo

Chief Medical Officer and Senior Vice President, Clinical Genomics, Illumina (USA)

Robert L. Grossman

Professor, Medicine-Computational Biomedicine and Biomedical Data Science, University of Chicago (USA)

Stanley R. Hamilton

Chair and Professor, Department of Pathology, City of Hope Comprehensive Cancer Center (USA)

Leroy Hood

Chief Strategy Officer, Co-founder and Professor, Institute for Systems Biology (USA)

Pasi A. Jänne

Director, Lowe Center for Thoracic Oncology and Scientific Director, Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute (USA)

Yves Luisser

Professor and Chair, Department of Biomedical Informatics, The University of Utah School of Medicine (USA)

John Quackenbush

Professor, Biostatistics & Computational Biology, Dana-Farber/Harvard Cancer Center (USA)

Gideon Rechavi

Head, Sheba Cancer Research Center, Chaim Sheba Medical Center (Israel)

Gary L. Rosner

Director of the Quantitative Sciences Program and Biostatistics/Bioinformatics Division, Department of Oncology, John Hopkins Medicine (USA)

Lillian Siu

Senior Scientist, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre (Canada)

Alan Spatz

Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)

Josep Tabernero

Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain); Past ESMO President (2019)

Yosef Yarden

Professor, Weizmann Institute of Science (Israel)

Gerald Batist

Professor & Chair, Department of Oncology, McGill University and Director, Segal Cancer Center (Canada)

Cristiano de Pádua Souza

Medical Oncologist, Department of Oncology, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Pierre Fumoleau

General Manager, Institut Curie Hospital Group, Paris (France)

Nicolas Girard

Head of Department, Medical Oncology, Institut Curie (France)

Razelle Kurzrock

Associate Director, Clinical Science, Director, Center for Personalized Cancer Therapy, Director, Rare Tumor Clinic, University of California San Diego Moores Cancer Center (USA)

Ulrik Lassen

Professor, Head of Phase 1 Unit, Rigshospitalet (Denmark)

Jean-François Martini

Senior Director, Translational Oncology, Global Product Development-Oncology, Pfizer, Inc. (USA)

Ni Ming

Director, Office of Shanghai Anti-cancer and Office of International Affairs, Fudan University Shanghai Cancer Center (China)

Amir Onn

Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Prithwish Pal

Associate Director, Medical Affairs - Oncology, Illumina (USA)

Alejandro Piris

Head of the Scientific Management Department, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Angel Porgador

Professor and Dean, Faculty of Health Sciences, Ben-Gurion University of the Negev (Israel)

C.S. Pramesh

Director, Tata Memorial Hospital; Professor and Head, Thoracic Surgery, Division of Surgical Oncology, Tata Memorial Centre (India)

Jacques Raynaud

Member of Board and Past President, Fondation ARC for cancer research (France), Advisor to Operational Team, WIN Consortium

Eitan Rubin

Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head Bioinformatics, WIN Consortium

Richard L. Schilsky

Principal Investigator, TAPUR Study, American Society of Clinical Oncology (ASCO); past ASCO Executive Vice President and Chief Medical Officer (2013-2021)

Marina Sekacheva

Head of Personalized Oncology Center & Vice-Rector for Research, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)

Benjamin M. Solomon

Asst Professor of Medicine, Avera Cancer Institute (USA)

Alan Spatz

Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)

Josep Tabernero

Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain); Past ESMO President (2019)

Casey Williams

Chief Scientific Officer and Executive Director of Cancer Research, Avera Cancer Institute (USA)

Hikmat Abdel-Razeq

Chief Medical Officer, Chief Medical officer and Deputy Director General King Hussein Cancer Center (Jordan)

Amal Al Omari

Chief Scientific Officer, King Hussein Cancer Center (Jordan)

Fabrice André

Head of Research and Professor in Department of Medical Oncology, Gustave Roussy (France)

Gerald Batist

Professor & Chair, Department of Oncology, McGill University and Director, Segal Cancer Center (Canada)

Guy Berchem

Head of Medical Oncology department, Centre Hospitalier de Luxembourg; Associate Medical Director, Luxembourg Institute of Health (Luxembourg)

Raanan Berger

Director, Institute of Oncology, Sheba Medical Center (Israel)

Jean-Yves Blay

Professor of Medicine, Université Claude Bernard; Scientific Director, Canceropole Lyon Rhône Alpes, Centre Léon Bérard (France)

Rares Buiga

Head of Pathology, The Oncology Institute Ion Chiricuta (IOCN) (Romania)

Anca Dana Buzoianu

Rector, The University of Medicine and Pharmacy Iuliu Haţieganu (Romania)

David Cantú de León

Deputy Director of Clinical Research, Instituto Nacional de Cancerologia (INCan)(Mexico)

Andrés Cervantes

Scientific Director, INCLIVA (Spain)

Zhen Chen

Vice President, Fudan University Shanghai Cancer Center (China)

Francesco De Lorenzo

Past President, Chair of the Scientific Committee, European Cancer Patient Coalition - ECPC (Belgium)

Tim Demuth

Head of Global Clinical Development, Oncology Global Development, Biopharma, Global Research & Development, Merck Group KGaA (Germany)

Cristiano de Pádua Souza

Medical Oncologist, Department of Oncology, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Michel Ducreux

Head of Digestive Oncology department, Gustave Roussy (France)

François Dupré

Director General, La Direction générale de la Fondation ARC, Fondation ARC (France)

Susan Galbraith

Senior Vice-President IMED Oncology, AstraZeneca(UK)

Manon Gantenbein

Head of Unit CIEC & CPMO, Clinical and Epidemiological Investigation Center, Luxembourg Institute of Health (Luxembourg)

Jean Claude Gerard

Senior Vice President European Operations, HTG Molecular (France)

Caroline Germa

Vice President, Head of the Clinical Group, AstraZeneca, Maryland (USA)

Nicolas Girard

Head of Department, Medical Oncology, Institut Curie (France)

Angel I. Guerrero-Zotano

Medical Oncologist, Instituto Valenciano de Oncología (IVO)(Spain)

Sadakatsu Ikeda

Associate Professor, Deputy Director, Tokyo Medical and Dental University Cancer Center (Japan)

Razelle Kurzrock

Associate Director, Clinical Science, Director, Center for Personalized Cancer Therapy, Director, Rare Tumor Clinic, University of California San Diego Moores Cancer Center (USA)

Ulrik Lassen

Professor, Head of Phase 1 Unit, Rigshospitalet (Denmark)

Scott M. Lippman

Director, University of California San Diego Moores Cancer Center (USA)

José Antonio López-Guerrero

Head of Laboratory, Molecular Biologist and Geneticist, Instituto Valenciano de Oncología (IVO)(Spain)

Juan Martín Liberal

Consultant Medical Oncologist Melanoma, Sarcoma and GU Tumors Unit Early Drug Development Unit, Catalan Institute of Oncology (ICO), Barcelona (Spain)

Jean-François Martini

Senior Director, Translational Oncology, Global Product Development-Oncology, Pfizer, Inc. (USA)

Giorgio Massimini

Vice President, External R&D, Merck Group KGaA (Germany)

Ni Ming

Director, Office of Shanghai Anti-cancer and Office of International Affairs, Fudan University Shanghai Cancer Center (China)

Satoshi Miyake

Director, Tokyo Medical and Dental University Cancer Center (Japan)

Ioana Berindan-Neagoe

Scientific Director, The University of Medicine and Pharmacy Iuliu Hatieganu (Romania)

Hovav Nechushtan

Associate Professor, Oncology Department, Hadassah Hebrew University Medical School (Israel)

Finn Cilius Nielsen

Professor and Head of Centre for Genomic Medicine, Rigshospitalet (Denmark)

Amir Onn

Chair, Institute of Pulmonary Oncology, Sheba Medical Center (Israel)

Prithwish Pal

Associate Director, Medical Affairs - Oncology, Illumina (USA)

Thierry Philip

Chairman of the Board of directors, Institut Curie (France)

Alejandro Piris

Head of the Scientific Management Department, Vall d'Hebron Institute of Oncology, VHIO (Spain)

Aron Popovtzer

Chairman, Hadassah Medical Center (Israel)

Angel Porgador

Professor and Dean, Faculty of Health Sciences, Ben-Gurion University of the Negev (Israel)

C.S. Pramesh

Director, Tata Memorial Hospital; Professor and Head, Thoracic Surgery, Division of Surgical Oncology, Tata Memorial Centre (India)

Eric Raymond

Head of Medical Oncology, Groupe Hospitalier Paris Saint-Joseph (France)

Jacques Raynaud

Member of Board and Past President, Fondation ARC for cancer research (France), Advisor to Operational Team, WIN Consortium

Rui Manuel Reis

Executive and Scientific Director, Research and Education Institute, Coordinator, Molecular Oncology Research Center, Fundaçao Pio XII - Hospital de Câncer de Barretos (Brazil)

Eitan Rubin

Senior Lecturer, Ben-Gurion University of the Negev (Israel); Head Bioinformatics, WIN Consortium

Joy Brewster Rusthoven

Executive Director, SURVIVEiT (USA)

Pierre Saintigny

Laboratory of Translational Research, Department of Translational Research and Innovation, Centre Léon Bérard (France)

Ramón Salazar

Head of Medical Oncology Department, Catalan Institute of Oncology (ICO), Barcelona, Spain

Marina Sekacheva

Head of Personalized Oncology Center & Vice-Rector for Research, I.M. Sechenov First Moscow State Medical University, Sechenov University (Russia)

Manju Sengar

Medical Oncologist and Officer in charge, Clinical Research Secretariat, ACTREC - Tata Memorial Center (India)

Benjamin M. Solomon

Asst Professor of Medicine, Avera Cancer Institute (USA)

Alan Spatz

Director, Department of Pathology & Professor of Pathology & Oncology, Jewish General Hospital & McGill University (Canada)

Andrey A. Svistunov

First Vice Rector for Innovation and International Affairs, I.M Sechenov First Moscow State Medical University (Russia)

Josep Tabernero

Head, Medical Oncology Department, Vall d'Hebron University Hospital (HUVH); Director, Vall d'Hebron Institute of Oncology, VHIO (Spain); Past ESMO President (2019)

Raaj Trivedi

Global Market Development, Illumina (USA)

Casey Williams

Chief Scientific Officer and Executive Director of Cancer Research, Avera Cancer Institute (USA)